Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic B7-H3 CAR-γδT Cell Therapy in R/R HGG
NCT06018363Phase 2Recruiting
- Sponsor
- Soochow University
- Start
- Jun 2023
- Primary completion
- Dec 2027
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of QH104 in glioma, sponsored by Soochow University. Started Jun 2023; status: recruiting.
02
Drugs
QH104
03
Conditions
glioma
Beyond the preview
Go deeper on NCT06018363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06018363.